Your browser doesn't support javascript.
loading
Relapse of BCR-ABL1-like ALL mediated by the ABL1 kinase domain mutation T315I following initial response to dasatinib treatment.
Yeung, D T; Moulton, D J; Heatley, S L; Nievergall, E; Dang, P; Braley, J; Branford, S; Moore, S; Mullighan, C G; Hughes, T P; White, D L.
Afiliação
  • Yeung DT; 1] Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia [2] Department of Genetics & Pathology & Centre for Cancer Biology, Adelaide, South Australia, Australia [3] Department of Haematology, SA Pathology, Adelaide, South Australia, Austral
  • Moulton DJ; 1] Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia [2] Department of Haematology, SA Pathology, Adelaide, South Australia, Australia [3] South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Heatley SL; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Nievergall E; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Dang P; South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • Braley J; Department of Genetics & Pathology & Centre for Cancer Biology, Adelaide, South Australia, Australia.
  • Branford S; Department of Genetics & Pathology & Centre for Cancer Biology, Adelaide, South Australia, Australia.
  • Moore S; Department of Genetics & Pathology & Centre for Cancer Biology, Adelaide, South Australia, Australia.
  • Mullighan CG; 1] Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia [2] South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia [3] St Jude Children's Research Hospital, Memphis, TN, USA.
  • Hughes TP; 1] Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia [2] Department of Haematology, SA Pathology, Adelaide, South Australia, Australia [3] South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • White DL; 1] Discipline of Medicine, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia [2] South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia [3] Discipline of Paediatrics, School of Medicine, University of Adelaide, Adelaide, South Austr
Leukemia ; 29(1): 230-2, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25179732
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Quinases / Pirimidinas / Tiazóis / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mutação Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Proteínas Quinases / Pirimidinas / Tiazóis / Proteínas de Fusão bcr-abl / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mutação Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article